Az elmlt vek sorn vilgszerte risi rdeklds vez egy, eredetileg a 2-es tpus cukorbetegsg kezelsre kifejlesztett gygyszercsoportot
Semaglutide robustly reduces appetite, promotes satiety, and significantly decreases body weight and glycemic parameters in both obese/overweight individuals and those with type 2 diabetes
Elucidating its regulatory pathways may offer new therapeutic opportunities for improving DOR
Science is trying to figure out why (The Independent) The media is having a field day pushing the idea that weight-loss drugs like Ozempic, Wegovy, and Mounjaro could be destroying peoples eyesight
Share: A major study from Cleveland Clinic found that people with both obesity and type 2 diabetes who had weight-loss surgery lived longer and experienced fewer serious health issues than those who used GLP-1 receptor agonist medications alone
The two-year study found that the supplementation improved B-vitamin status, decreased homocysteine concentrations, and reduced risk of total fractures compared to placebo (117)